LAS VEGAS — Instead of using one donor cornea for one patient, endothelial cell therapy may allow tissue from one donor to be used by as many as 100 patients, according to a study.
Edward J. Holland, MD, presented findings from the IOTA trial during the Richard L. Lindstrom, MD, Medal Lecture at the American Society of Cataract and Refractive Surgery meeting. The IOTA trial included the first successful injectable corneal endothelial cell therapy (Aurion Biotech) procedures performed outside of Japan, where it was first developed by Shigeru Kinoshita, MD, PhD, and colleagues at Kyoto